ClinicalTrials.gg
RecruitingNCT07169526GESAUpdated Sep 11, 2025

Health Literacy and Self-efficacy Expectations in Patients With Alcohol-related Liver Cirrhosis

An observational study in Self-Efficacy, Health Literacy and Liver Cirrhosis, sponsored by Hannover Medical School. Recruiting at 1 site in Germany. Open to participants aged 18 Years to 99 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-09-11.

Sponsored by Hannover Medical School · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Aug 2026, 3 months ago, but the record still lists the study as recruiting.
  • Started Aug 2025; still recruiting 1 year 3 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
200
Ages
18 Years to 99 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 82 studies in Liver Cirrhosis with a site in Germany — 24 open to participants now, 27 under way, 2 of them phase 3. Liver Cirrhosis · Germany.

Planned enrollment
19th of 37
200 · median 200
Started
2025
with 2 others
Observational
37 of 82
15 open now
Primary completion
2026-08
later than 10 of 26 live
Registered
77th of 82
by date
Lead sponsor
5 of 82
Hannover Medical School

Among the 82 studies in Liver Cirrhosis with a site in Germany, this one is the 19th largest by planned enrollment of the 37 observational ones that give a count, is one of 3 that started in 2025, is one of 37 observational ones, reaches primary completion later than 10 of the 26 other live ones, and was the 77th registered.

Liver Cirrhosis

1,303 studies on the registry are indexed under Liver Cirrhosis; 341 are open to participants now.

Browse Liver Cirrhosis studies →

Open to participants now

24 of the 82 studies in Liver Cirrhosis with a site in Germany are open now. Recruiting first, the newest first:

18 more — sign in →

All 24 open studies →

A study can be open while its sites in Germany have not opened yet or have stopped. Only those recruiting at a site in Germany →

Who these studies take

Of the 208 Liver Cirrhosis studies recruiting now, 101 (49%) set no upper age limit and 66 (32%) stop at 75 or younger; 12 take children under 18; 25 take healthy volunteers.

This study: 18 Years to 99 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 82 studies in Liver Cirrhosis with a site in Germany, or all of them as a file.
02

Study summary

The goal of this observational study is to quantify the health literacy and self-efficacy in people with alcohol-related liver cirrhosis.

03

Conditions studied

  • Self-Efficacy
  • Health Literacy
  • Liver Cirrhosis
  • ALD - Alcoholic Liver Disease
04

Who can participate

Ages eligible
18 Years to 99 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

people with liver cirrhosis

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • age (18-99)
  • liver cirrhosis

Exclusion criteria

Exclusion Criteria:

  • pregnancy
  • insufficient german
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
200 participants (estimated)
Target follow-up
1 Month
Patient registry
Yes
06

What researchers measure

Primary outcomes

  1. Level of self-efficacy at baseline, assessed using the Scale for General Self-Efficacy (Skala zur Allgemeinen Selbstwirksamkeitserwartung)

    Time frame: baseline

  2. Level of health literacy at baseline, assessed using the European Health Literacy Survey Questionnaire (HLS-EU-Q47)

    Time frame: baseline

Secondary outcomes

  1. Occurrence of hepatic decompensation or liver-related death

    Time frame: until end of study

  2. Rehospitalization due to liver-related complications

    Time frame: Throughout study completion (up to 12 months)

  3. Hepatic decompensation episodes

    Time frame: Throughout study completion (up to 12 months)

  4. Level of quality of life, assessed using the [e.g., SF-36 Questionnaire]

    Time frame: baseline

07

Study locations

1 of 1 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Aug 2025 (actual). Primary completion is estimated for Aug 2026, 12 months after the start.

Of 231 non-industry observational studies under Liver Cirrhosis, half reached primary completion within 47 months of starting (the median), counting those still running; a quarter within 19 and three quarters within 71. This study's planned 12 months is below that.

Counting every sponsor, half of 247 studies reached it within 47 months; a quarter within 18 and three quarters within 71.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 3, 2025
First posted
Sep 11, 2025
StartActual
Aug 11, 2025
Primary completionEst.
Aug 2026
CompletionEst.
Oct 2026
Last update
Sep 11, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 11, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07169526
Responsible party
Sponsor
First posted
Sep 11, 2025
Start date
Aug 11, 2025
Primary completion
Aug 2026 (estimated)
Completion
Oct 2026 (estimated)
Last update
Sep 11, 2025

Study contacts

Benjamin Prof. Dr. med. Maasoumy, Prof. Dr. med.
Contact
maasoumy.benjamin@mh-hannover.de
+495115326529

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion